Pricing | New Products | Formulary News | DIN Changes | Packaging Company News NOW AVAILABLE Valeo Pharma Inc. is pleased to introduce: Pr VAL-VANCO® RE: Update regarding rosiglitazone-containing medicines (Sterile Vancomycin Hydrochloride USP)
In light of the recent announcements by the EU and FDA, we wanted to update you regarding rosiglitazone-containing
500 mg and 1 g Box of 10 vials Avandia®, Avandamet® and Avandaryl® continue to be Pr VAL-VANCO® can be ordered from your local wholesaler. available to Canadian Health Care Professionals and patients. GlaxoSmithKline (GSK) continues to believe Amerisource that rosiglitazone-containing medicines are important treatment options for patients with type 2 diabetes. GSK is continuing to work with Health Canada on its review of rosiglitazone-containing medicines.
For more information, please contact Valeo Pharma Inc. at
In the European Union, the EMA has suspended the marketing
authorization for all rosiglitazone-containing medicines. As a result, physicians in Europe are being advised that affected patients need to be transitioned to alternative treatment options.
In the US, all rosiglitazone-containing medicines will remain available with additional safety labeling and restrictions for use.
In addition, GSK has decided to voluntarily cease promotion of rosiglitazone-containing medicines in all the countries, including Canada. However, it is important to note, that we will continue to respond to requests for information and support healthcare
MISSISSAUGA: Valeant Pharmaceuticals International, Inc.
announced the completion of the merger of Biovail Corpo-
Patients using rosiglitazone-containing medicines who have
ration (“Biovail”) and Valeant Pharmaceuticals International
questions regarding their current treatment should be referred
(“Valeant”) following the approval of the merger by share-
to their respective healthcare team.
If you have any questions please contact GSK’s Medical Information Department at 1-800-387-7374. OTTAWA: The Canadian Association of Radiologists (CAR) recently contributed to a report produced by the Health Coun-
cil of Canada (HCC) entitled “Decisions, Decisions: Family Doctors as Gatekeepers in the Use of Prescription Drugs
SHIRE CANADA INC. – Discontinues AMATINE®
and Diagnostic Imaging in Canada.” This report, which was
(Midodrine hydrochloride) 2.5mg & 5mg
released today, supports one of the CAR’s main objectives:
Shire Canada Inc. regrets to announce the discontinuation of
to implement medical imaging guidelines at a national level
the following product, on September 30th 2010 or when current
to guide physicians in selecting the most effective diagnostic
WINNIPEG: IMRIS Inc. today announced the appointment
of Robert Burgess to the Company’s board of directors. Mr.
Burgess joins the IMRIS board with a wealth of corporate ex-
If you should have any questions, please call 1-800-268-2772.
perience. He is currently a member of the board of directors
of Adobe Systems Incorporated (Nasdaq:ADBE) and is also a board member for a number of private companies.
Copyright 2010 Health Response of Canada. All rights reserved. Please advise changes to: Tel: 416 863-5403 or email: [email protected]
16 Dhou El Hidja 1429 JOURNAL OFFICIEL DE LA REPUBLIQUE ALGERIENNE N ° 70 14 décembre 2008 L’importateur ayant présenté un dossierArt. 32. — Le présent cahier des conditions techniquesd’investissement conforme à la législation et à laà l’importation est applicable à compter de la date de saréglementation en vigueur, peut prétendre à uneimportation de produits ph
Using Machine Learning Algorithms to Detect Cellular Stress of Listeria monocytogenes from cDNA Microarray Data Xiaoji Liu1, Urmila Basu1, Petr Miller1, Nasimeh Asgarian2, Russell Greiner2, Lynn M. McMullen1 University of Alberta, Department of Agricultural, Food and Nutritional Science, Edmonton, AB, Canada1, University of Alberta, Department of Computing Scien